Open letter sent by fax and email to the Indian Prime Minister (copied to the Hon. Minster of External Affairs of India and the Hon. Minster of Commerce and Industry of India)
- PhRMA is angered by Colombia’s move to cut prices for hepatitis C drugs
- Global Summit On IP And Access Discusses Impact Of TRIPS-Plus Measures On Public Health
- RCEP: India in a Catch-22
- Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
- Cancer Drug Price Rises 1, 400% With No Generic to Challenge It